Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy

MG Shah-Khan, XJ Geiger, C Reynolds… - Annals of surgical …, 2012 - Springer
Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

Observation versus excision of lobular neoplasia on core needle biopsy of the breast

H Schmidt, B Arditi, M Wooster, C Weltz… - Breast cancer research …, 2018 - Springer
Purpose Controversy surrounds management of lobular neoplasia (LN),[atypical lobular
hyperplasia (ALH) or lobular carcinoma in situ (LCIS)], diagnosed on core needle biopsy …

Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases

M O'Neil, R Madan, OW Tawfik, PA Thomas… - Annals of Diagnostic …, 2010 - Elsevier
Lobular neoplasia including lobular carcinoma in situ (LCIS) and atypical lobular
hyperplasia (ALH) may be identified in breast core needle biopsies as incidental findings or …

Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow‐up in a …

LP Middleton, N Sneige, R Coyne, Y Shen… - Cancer …, 2014 - Wiley Online Library
We evaluated the efficacy of using standard radiologic and histologic criteria to guide the
follow‐up of patients with lobular carcinoma in situ (LCIS), lobular neoplasia (LN), or atypical …

Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study

IS Genco, B Tugertimur, Q Chang, L Cassell… - Virchows Archiv, 2020 - Springer
Management of classic lobular neoplasia (cLN) diagnosed on core needle biopsy (CNB) is
controversial. Our aim in this study was to review cases of cLN diagnosed on CNB to …

Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 …

J Cangiarella, A Guth, D Axelrod… - … of pathology & …, 2008 - meridian.allenpress.com
Context.—Both atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) have
traditionally been considered to be risk factors for the development of invasive carcinoma …

Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast–a review

M Hussain, GH Cunnick - European Journal of Surgical Oncology, 2011 - Elsevier
OBJECTIVES: To determine the incidence of malignancy (invasive carcinoma or DCIS) in
patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast …

Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia: a systematic review and meta-analysis

MN Shehata, H Rahbar, MR Flanagan… - Journal of the American …, 2020 - Elsevier
Purpose Lobular neoplasia (LN) detected on breast core needle biopsy is frequently
managed with surgical excision because of concern for undersampled malignancy. The …

Lobular neoplasia on core needle biopsy does not require excision

CS Nagi, JE O'Donnell, M Tismenetsky, IJ Bleiweiss… - Cancer, 2008 - Wiley Online Library
Abstract BACKGROUND. Lobular neoplasia (LN), encompassing atypical lobular
hyperplasia (ALH) and lobular carcinoma in situ (LCIS), is often an incidental finding on core …

Core breast biopsies showing lobular carcinoma in situ should be excised and surveillance is reasonable for atypical lobular hyperplasia

LQC Sen, WA Berg, RJ Hooley… - American Journal of …, 2016 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …